Page last updated: 2024-10-22

alendronate and Urolithiasis

alendronate has been researched along with Urolithiasis in 2 studies

alendronic acid : A 1,1-bis(phosphonic acid) that is methanebis(phosphonic acid) in which the two methylene hydrogens are replaced by hydroxy and 3-aminopropyl groups.

Urolithiasis: Formation of stones in any part of the URINARY TRACT, usually in the KIDNEY; URINARY BLADDER; or the URETER.

Research Excerpts

ExcerptRelevanceReference
"Osteoporosis is characterized by a reduction in bone mineral density (BMD) ."2.47[New therapy using bisphosphonate for urolithiasis]. ( Hirose, M; Niimi, K; Yasui, T, 2011)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mellema, M1
Stoller, M1
Queau, Y1
Ho, SP1
Chi, T1
Larsen, JA1
Passlack, N1
Fascetti, AJ1
Mohr, C1
Westropp, JL1
Yasui, T1
Niimi, K1
Hirose, M1

Reviews

1 review available for alendronate and Urolithiasis

ArticleYear
[New therapy using bisphosphonate for urolithiasis].
    Clinical calcium, 2011, Volume: 21, Issue:10

    Topics: Alendronate; Animals; Bed Rest; Bone and Bones; Bone Density Conservation Agents; Bone Resorption; C

2011

Other Studies

1 other study available for alendronate and Urolithiasis

ArticleYear
Nanoparticle Tracking Analysis for the Enumeration and Characterization of Mineralo-Organic Nanoparticles in Feline Urine.
    PloS one, 2016, Volume: 11, Issue:12

    Topics: Alendronate; Animals; Calcifying Nanoparticles; Cats; Citric Acid; Durapatite; Female; Fluorescent D

2016